lung cancer
Smoking stokes cells’ cancer capacity
Mar. 23, 2012—Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.
Drugs reverse lung cancer cell changes
Feb. 1, 2012—Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
Lung nodule surgery not always “futile”
Dec. 7, 2011—Even when lung operations for suspected cancer resection results in a benign diagnosis, there still may be significant benefits to the procedure, new research suggests.
Study suggests new lung cancer therapy schedule
Aug. 10, 2011—A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others.
Vanderbilt: Laboratory for health care reform
Apr. 15, 2011—Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and nurses to chart in exquisite...
Cancer Center study snuffs out menthol myths
Mar. 24, 2011—People who smoke mentholated cigarettes are no more likely to develop lung cancer or die from the disease than are smokers of non-mentholated brands, a new study shows.
“Did you smoke?”
Mar. 7, 2011—“Did you smoke?” It’s the first question lung cancer patients are asked. Is this smoking stigma choking progress in lung cancer?
Vanderbilt-Ingram Cancer Center launches online genetic research tool
Mar. 3, 2011—A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.